The chemical class of FSD1 activators, based on the current understanding, primarily consists of compounds that modulate signaling pathways and extracellular matrix dynamics. These activators operate through diverse mechanisms, including inhibition of growth factor signaling, modulation of extracellular matrix remodeling enzymes, and antagonism of cell adhesion molecules.
For instance, TGF-β inhibitors, MMP inhibitors, and integrin antagonists might indirectly affect FSD1 by altering the extracellular matrix environment and cell-matrix interactions. Inhibitors of signaling pathways like PDGF, FGFR, Wnt, and the MAPK pathway (through MEK inhibitors) demonstrate the ability for modulation of signaling cascades that could indirectly influence FSD1. Additionally, compounds targeting protein stability and folding, such as HSP90 inhibitors, and those affecting key kinases in signaling pathways, like Src and ROCK inhibitors, provide insight into the complex interplay between cellular signaling and extracellular matrix dynamics. PI3K and JAK/STAT inhibitors further expand this class by targeting fundamental cellular processes, indicating the diverse mechanisms through which cellular signaling and interactions can be modulated, thereby influencing FSD1's activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
TGF-β signaling is involved in extracellular matrix formation; inhibitors can indirectly affect proteins like FSD1. | ||||||
Marimastat | 154039-60-8 | sc-202223 sc-202223A sc-202223B sc-202223C sc-202223E | 5 mg 10 mg 25 mg 50 mg 400 mg | $168.00 $218.00 $404.00 $629.00 $4900.00 | 19 | |
Matrix metalloproteinases (MMPs) remodel the extracellular matrix; their inhibitors could indirectly influence FSD1. | ||||||
Cilengitide | 188968-51-6 | sc-507335 | 5 mg | $215.00 | ||
Integrins are crucial for cell-matrix interactions; antagonists might indirectly affect FSD1's role in the matrix. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
PDGF signaling affects cell growth and matrix interactions; inhibitors could influence FSD1 indirectly. | ||||||
AZD4547 | 1035270-39-3 | sc-364421 sc-364421A | 5 mg 10 mg | $198.00 $309.00 | 6 | |
FGFR signaling is involved in cell growth and tissue repair; inhibitors may have indirect effects on FSD1. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $36.00 $117.00 $525.00 | 26 | |
The Wnt signaling pathway influences extracellular matrix dynamics; inhibitors might affect FSD1 indirectly. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
HSP90 is involved in protein folding and stability; inhibitors could indirectly affect FSD1-related pathways. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
Src kinase is involved in signaling pathways related to the extracellular matrix; inhibitors might impact FSD1. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK signaling affects cell motility and matrix interactions; inhibitors could indirectly influence FSD1. | ||||||
Ruxolitinib | 941678-49-5 | sc-364729 sc-364729A sc-364729A-CW | 5 mg 25 mg 25 mg | $251.00 $500.00 $547.00 | 16 | |
JAK/STAT signaling is involved in various cellular processes; inhibitors could influence FSD1 indirectly. | ||||||